V

Researcher Profile

Veronique Leblond

🏛 Service d'Hématologie Clinique, Sorbonne University, Pitié Salpêtrière Hospital, Paris, France;

4

Publications

1,013

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article Blood Oct 29, 2020

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam · Stephen Opat · Shirley D'Sa · Wojciech Jurczak +29 more

10.1182/blood.2020006844 421 citations

Journal Article Blood Nov 19, 2020

CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell–targeted therapies

Marie Le Cann · Françoise Bouhour · Karine Viala · Laurence Simon +17 more

10.1182/blood.2020007092 61 citations

Journal Article Journal of Clinical Oncology Feb 10, 2017

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial

Ralf U. Trappe · Daan Dierickx · Heiner Zimmermann · Franck Morschhauser +19 more

10.1200/jco.2016.69.3564 195 citations

Journal Article The Lancet Oncology Feb 01, 2012

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Ralf Trappe · Stephan Oertel · Veronique Leblond · Peter Mollee +15 more

10.1016/s1470-2045(11)70300-x 336 citations

Publication Timeline

2020

2

2017

1

2012

1

Frequent Co-Authors

Ioannis Anagnostopoulos

Franck Morschhauser

Sylvain Choquet

Heiner Zimmermann